Philip J. Vickers

This profile gathers the share dealings of Philip J. Vickers across 2 companies, led by Revance Therapeutics, Inc. and Tectonic Therapeutic, Inc. Over a trading history stretching from 5 May 2021 to 4 May 2022, the count stands at 3 filings.

Every open-market trade on record is a purchase: 1 purchase worth €34k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants.

The latest filing, published on 6 May 2022, reports a share grant in Revance Therapeutics, Inc. The most recent open-market purchase was published on 8 July 2021, 1,929 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.